Deferred Tax Assets, Valuation Allowance of VBI Vaccines Inc/BC from 31 Dec 2015 to 31 Dec 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: VBI Vaccines Inc/BC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2023.
VBI Vaccines Inc/BC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2023 was $116,717,000, a 18% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

VBI Vaccines Inc/BC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2023	$116,717,000	+$18,137,000	+18%	31 Dec 2023	10-K	16 Apr 2024	2023	FY
Q4 2022	$98,580,000	+$11,411,000	+13%	31 Dec 2022	10-K	16 Apr 2024	2023	FY
Q4 2021	$87,169,000	+$18,944,000	+28%	31 Dec 2021	10-K	13 Mar 2023	2022	FY
Q4 2020	$68,225,000	+$15,242,000	+29%	31 Dec 2020	10-K	07 Mar 2022	2021	FY
Q4 2019	$52,983,000	+$10,873,000	+26%	31 Dec 2019	10-K	02 Mar 2021	2020	FY
Q4 2018	$42,110,000	+$14,685,000	+54%	31 Dec 2018	10-K	05 Mar 2020	2019	FY
Q4 2017	$27,425,000	+$49,354,000		31 Dec 2017	10-K	25 Feb 2019	2018	FY
Q4 2016	$21,929,000	-$16,161,000	-280%	31 Dec 2016	10-K	26 Feb 2018	2017	FY
Q4 2015	$5,768,000			31 Dec 2015	10-K	20 Mar 2017	2016	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.